June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Restoration of light sensitivity to blind mice with red-shifted chemical photoswitches
Author Affiliations & Notes
  • Ivan Tochitsky
    Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA
  • Aleksandra Polosukhina
    Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA
  • Andrew Noblet
    Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA
  • Dirk Trauner
    Department Chemie, Ludwig-Maximilians-Universität München, München, Germany
  • Richard Kramer
    Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA
  • Footnotes
    Commercial Relationships Ivan Tochitsky, None; Aleksandra Polosukhina, None; Andrew Noblet, None; Dirk Trauner, None; Richard Kramer, Photoswitch Biosciences (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 1400. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Ivan Tochitsky, Aleksandra Polosukhina, Andrew Noblet, Dirk Trauner, Richard Kramer; Restoration of light sensitivity to blind mice with red-shifted chemical photoswitches. Invest. Ophthalmol. Vis. Sci. 2013;54(15):1400.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Degenerative blinding diseases such as retinitis pigmentosa and age-related macular degeneration affect millions of patients around the world. These disorders cause the progressive loss of rod and cone photoreceptors in the retina, while sparing the remaining amacrine, bipolar and retinal ganglion cells. Visual function can be restored to a blind retina through gene delivery of light-sensitive ion channels to the remaining retinal neurons. However, gene therapy can also produce an unfavorable immune response or cause cancer. It would thus be highly desirable to develop more conventional pharmaceutical means of restoring light sensitivity to a blind retina. Our goal is to develop and test such pharmacological therapies.

Methods: We have created several small molecule chemical “photoswitches” that can be used to control the activity of neurons by reversibly blocking native ion channels in response to light. In order to evaluate the ability of these photoswitches to restore light sensitivity to blind mice, we have tested them in an rd1 mouse model of retinitis pigmentosa. Our in vitro assays were carried out using a multi-electrode array (MEA). We also tested the restoration of visually guided behavior in vivo in several assays.

Results: We have previously demonstrated that the photoswitch AAQ restores light responses to blind retinas in vitro and also restores the pupillary light reflex and light-aversive behaviors in blind mice. Now, we present the restoration of light sensitivity to blind mice in vitro and in vivo with two improved photoswitch molecules, DENAQ and BENAQ. Unlike AAQ, DENAQ and BENAQ do not require the use of ultraviolet light and can be used to photosensitize the retina to visible (blue-green) light. These red-shifted molecules photosensitize the retinas of blind rd1 mice in vitro. The photoswitches persist up to several weeks in vivo and are well tolerated in the eye. DENAQ and BENAQ are selective for degenerated rather than healthy retinal tissue. Intravitreal injection of DENAQ also restores light sensitivity to rd1 mice in vivo in an exploratory locomotory behavioral assay.

Conclusions: Red-shifted chemical photoswitches such as DENAQ and BENAQ, and our pharmacological approach in general, hold great promise for restoring visual function in end-stage degenerative blinding diseases.

Keywords: 696 retinal degenerations: hereditary • 412 age-related macular degeneration • 608 nanomedicine  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×